Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2022 | OriginalPaper | Hoofdstuk

7. Neurologische aandoeningen – ziekte van Parkinson

Auteur: Dr. M. J. Nijkrake

Gepubliceerd in: Geriatrie in de fysiotherapie en kinesitherapie - praktijk

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

De ziekte van Parkinson is een neurodegeneratieve aandoening waarvan het aantal patiënten in snel tempo toeneemt. Zowel motorische als niet-motorische symptomen zorgen voor een heterogeen beeld met een grote impact op de kwaliteit van leven. De meeste mensen met de ziekte van Parkinson gebruiken dopaminerge medicatie om het tekort van de neurotransmitter dopamine aan te vullen of om de dopaminereceptoren gevoeliger te maken. Langdurig gebruik van deze medicatie kan hinderlijke bijwerkingen geven. Sommige mensen ondergaan een geavanceerde behandeling zoals diepe hersenstimulatie. Omdat het beloop langzaam progressief is en er al vroeg in de ziekte beperkingen worden ervaren, maakt het merendeel gebruik van paramedische zorg, waaronder vooral fysiotherapie/kinesitherapie. Er zijn hierbij aanwijzingen dat bewegen het beloop van de ziekte gunstig beïnvloedt en fysiotherapie gericht op lopen, balans en transfers doelmatig is. In deze casus wordt specifiek ingegaan op een iets minder bekend domein, namelijk dat van complexe houdingsafwijkingen.
Literatuur
1.
go back to reference Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson’s disease. Lancet, 397(10291), 2284–2303. CrossRef Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson’s disease. Lancet, 397(10291), 2284–2303. CrossRef
2.
go back to reference Dorsey, E. R., & Bloem, B. R. (2018). The Parkinson Pandemic-A Call to Action. JAMA Neurology, 75(1), 9–10. CrossRef Dorsey, E. R., & Bloem, B. R. (2018). The Parkinson Pandemic-A Call to Action. JAMA Neurology, 75(1), 9–10. CrossRef
3.
go back to reference Maresova, P., Klimova, B., & Kuca, K. (2017). Medical and non-medical costs of Parkinson disease – comparison of Europe, USA, Asia an Australia. Ceska a Slovenska Farmacie, 66(1), 3–8. Maresova, P., Klimova, B., & Kuca, K. (2017). Medical and non-medical costs of Parkinson disease – comparison of Europe, USA, Asia an Australia. Ceska a Slovenska Farmacie, 66(1), 3–8.
4.
go back to reference Braak, H., et al. (2004). Stages in the development of Parkinson’s disease-related pathology. Cell and Tissue Research, 318(1), 121–134. CrossRef Braak, H., et al. (2004). Stages in the development of Parkinson’s disease-related pathology. Cell and Tissue Research, 318(1), 121–134. CrossRef
5.
go back to reference Kalia, L. V., & Lang, A. E. (2015). Parkinson’s disease. Lancet, 386(9996), 896–912. CrossRef Kalia, L. V., & Lang, A. E. (2015). Parkinson’s disease. Lancet, 386(9996), 896–912. CrossRef
6.
go back to reference McFarland, N. R. (2016). Diagnostic approach to atypical Parkinsonian syndromes . Continuum (Minneap Minn), 22(4 Movement Disorders), 1117–1142. McFarland, N. R. (2016). Diagnostic approach to atypical Parkinsonian syndromes . Continuum (Minneap Minn), 22(4 Movement Disorders), 1117–1142.
7.
go back to reference Backstrom, D., et al. (2018). Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study. Neurology, 91(22), e2045–e2056. CrossRef Backstrom, D., et al. (2018). Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study. Neurology, 91(22), e2045–e2056. CrossRef
8.
go back to reference Richtlijn Ziekte van Parkinson 2020, NVN/VRA. Richtlijn Ziekte van Parkinson 2020, NVN/VRA.
9.
go back to reference Munneke, M., et al. (2010). Efficacy of community-based physiotherapy networks for patients with Parkinson’s disease: A cluster-randomised trial. Lancet Neurology, 9(1), 46–54. CrossRef Munneke, M., et al. (2010). Efficacy of community-based physiotherapy networks for patients with Parkinson’s disease: A cluster-randomised trial. Lancet Neurology, 9(1), 46–54. CrossRef
10.
go back to reference Ypinga, J. H. L., et al. (2018). Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: A retrospective analysis of medical claims data. Lancet Neurology, 17(2), 153–161. CrossRef Ypinga, J. H. L., et al. (2018). Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: A retrospective analysis of medical claims data. Lancet Neurology, 17(2), 153–161. CrossRef
11.
go back to reference Nimwegen, M. v., et al. (2017). KNGF-richtlijn Ziekte van Parkinson, KNGF, Editor. Nimwegen, M. v., et al. (2017). KNGF-richtlijn Ziekte van Parkinson, KNGF, Editor.
12.
go back to reference Radder, D. L. M., et al. (2020). Physiotherapy in Parkinson’s disease: A meta-analysis of present treatment modalities. Neurorehabilitation and Neural Repair, 34(10), 871–880. CrossRef Radder, D. L. M., et al. (2020). Physiotherapy in Parkinson’s disease: A meta-analysis of present treatment modalities. Neurorehabilitation and Neural Repair, 34(10), 871–880. CrossRef
13.
go back to reference Baille, G., et al. (2018). Early occurrence of inspiratory muscle weakness in Parkinson’s disease . PLoS One, 13(1), e0190400. Baille, G., et al. (2018). Early occurrence of inspiratory muscle weakness in Parkinson’s disease . PLoS One, 13(1), e0190400.
14.
go back to reference Van de Wetering-van Dongen, V. A., et al. (2020). The effects of respiratory training in Parkinson’s disease: A systematic review. Journal of Parkinson’s Disease, 10(4), 1315–1333. CrossRef Van de Wetering-van Dongen, V. A., et al. (2020). The effects of respiratory training in Parkinson’s disease: A systematic review. Journal of Parkinson’s Disease, 10(4), 1315–1333. CrossRef
15.
go back to reference Claus, I., et al. (2021). Expiratory muscle strength training for therapy of pharyngeal dysphagia in Parkinson’s disease. Movement Disorders. Claus, I., et al. (2021). Expiratory muscle strength training for therapy of pharyngeal dysphagia in Parkinson’s disease. Movement Disorders.
16.
go back to reference Troche, M. S., et al. (2010). Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: A randomized trial. Neurology, 75(21), 1912–1919. CrossRef Troche, M. S., et al. (2010). Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: A randomized trial. Neurology, 75(21), 1912–1919. CrossRef
17.
go back to reference Hobson, P., & Meara, J. (2018). Mortality and quality of death certification in a cohort of patients with Parkinson’s disease and matched controls in North Wales, UK at 18 years: A community-based cohort study. BMJ Open, 8(2), e018969. Hobson, P., & Meara, J. (2018). Mortality and quality of death certification in a cohort of patients with Parkinson’s disease and matched controls in North Wales, UK at 18 years: A community-based cohort study. BMJ Open, 8(2), e018969.
18.
go back to reference Duncan, R. P., Leddy, A. L., & Earhart, G. M. (2011). Five times sit-to-stand test performance in Parkinson’s disease. Archives of Physical Medicine and Rehabilitation, 92(9), 1431–1436. CrossRef Duncan, R. P., Leddy, A. L., & Earhart, G. M. (2011). Five times sit-to-stand test performance in Parkinson’s disease. Archives of Physical Medicine and Rehabilitation, 92(9), 1431–1436. CrossRef
19.
go back to reference Winser, S. J., et al. (2019). Measures of balance and falls risk prediction in people with Parkinson’s disease: A systematic review of psychometric properties. Clinical Rehabilitation, 33(12), 1949–1962. CrossRef Winser, S. J., et al. (2019). Measures of balance and falls risk prediction in people with Parkinson’s disease: A systematic review of psychometric properties. Clinical Rehabilitation, 33(12), 1949–1962. CrossRef
20.
go back to reference Snijders, A. H., et al. (2011). Bicycling breaks the ice for freezers of gait. Movement Disorders, 26(3), 367–371. CrossRef Snijders, A. H., et al. (2011). Bicycling breaks the ice for freezers of gait. Movement Disorders, 26(3), 367–371. CrossRef
21.
go back to reference Steffen, T., & Seney, M. (2008). Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Physical Therapy, 88(6), 733–746. CrossRef Steffen, T., & Seney, M. (2008). Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Physical Therapy, 88(6), 733–746. CrossRef
22.
go back to reference Speelman, A. D., et al. (2012). Cardiovascular responses during a submaximal exercise test in patients with Parkinson’s disease. Journal of Parkinson’s Disease, 2(3), 241–247. CrossRef Speelman, A. D., et al. (2012). Cardiovascular responses during a submaximal exercise test in patients with Parkinson’s disease. Journal of Parkinson’s Disease, 2(3), 241–247. CrossRef
23.
go back to reference Doherty, K. M., et al. (2011). Postural deformities in Parkinson’s disease. Lancet Neurology, 10(6), 538–549. CrossRef Doherty, K. M., et al. (2011). Postural deformities in Parkinson’s disease. Lancet Neurology, 10(6), 538–549. CrossRef
24.
go back to reference Barone, P., et al. (2016). Pisa syndrome in Parkinson’s disease and parkinsonism: Clinical features, pathophysiology, and treatment. Lancet Neurology, 15(10), 1063–1074. CrossRef Barone, P., et al. (2016). Pisa syndrome in Parkinson’s disease and parkinsonism: Clinical features, pathophysiology, and treatment. Lancet Neurology, 15(10), 1063–1074. CrossRef
25.
go back to reference Margraf, N. G., et al. (2017). Clinical Definition of Camptocormia in Parkinson’s Disease. Mov Disord Clin Pract, 4(3), 349–357. CrossRef Margraf, N. G., et al. (2017). Clinical Definition of Camptocormia in Parkinson’s Disease. Mov Disord Clin Pract, 4(3), 349–357. CrossRef
26.
go back to reference Geroin, C., et al. (2017). Pisa syndrome in Parkinson’s disease: Electromyographic quantification of paraspinal and non-paraspinal muscle activity. Functional Neurology, 32(3), 143–151. CrossRef Geroin, C., et al. (2017). Pisa syndrome in Parkinson’s disease: Electromyographic quantification of paraspinal and non-paraspinal muscle activity. Functional Neurology, 32(3), 143–151. CrossRef
27.
go back to reference Gandor, F., et al. (2016). Subjective visual vertical in PD patients with lateral trunk flexion. Parkinson’s Disease, 2016, 7489105. PubMedPubMedCentral Gandor, F., et al. (2016). Subjective visual vertical in PD patients with lateral trunk flexion. Parkinson’s Disease, 2016, 7489105. PubMedPubMedCentral
28.
go back to reference Visser, J. E., & Bloem, B. R. (2005). Role of the basal ganglia in balance control. Neural Plasticity, 12(2–3), 161–174; discussion 263–272. Visser, J. E., & Bloem, B. R. (2005). Role of the basal ganglia in balance control. Neural Plasticity, 12(2–3), 161–174; discussion 263–272.
29.
go back to reference Gandolfi, M., et al. (2019). Four-week trunk-specific exercise program decreases forward trunk flexion in Parkinson’s disease: A single-blinded, randomized controlled trial. Parkinsonism & Related Disorders, 64, 268–274. CrossRef Gandolfi, M., et al. (2019). Four-week trunk-specific exercise program decreases forward trunk flexion in Parkinson’s disease: A single-blinded, randomized controlled trial. Parkinsonism & Related Disorders, 64, 268–274. CrossRef
30.
go back to reference Capecci, M., et al. (2014). Postural rehabilitation and Kinesio taping for axial postural disorders in Parkinson’s disease. Archives of Physical Medicine and Rehabilitation, 95(6), 1067–1075. CrossRef Capecci, M., et al. (2014). Postural rehabilitation and Kinesio taping for axial postural disorders in Parkinson’s disease. Archives of Physical Medicine and Rehabilitation, 95(6), 1067–1075. CrossRef
31.
go back to reference Baille, G., et al. (2016). Ventilatory dysfunction in Parkinson’s disease. Journal of Parkinson’s Disease, 6(3), 463–471. CrossRef Baille, G., et al. (2016). Ventilatory dysfunction in Parkinson’s disease. Journal of Parkinson’s Disease, 6(3), 463–471. CrossRef
32.
go back to reference Abbruzzese, G., Trompetto, C., & Marinelli, L. (2009). The rationale for motor learning in Parkinson’s disease. European Journal of Physical and Rehabilitation Medicine, 45(2), 209–214. PubMed Abbruzzese, G., Trompetto, C., & Marinelli, L. (2009). The rationale for motor learning in Parkinson’s disease. European Journal of Physical and Rehabilitation Medicine, 45(2), 209–214. PubMed
33.
go back to reference Reyes, A., et al. (2018). The effects of respiratory muscle training on peak cough flow in patients with Parkinson’s disease: A randomized controlled study. Clinical Rehabilitation, 32(10), 1317–1327. CrossRef Reyes, A., et al. (2018). The effects of respiratory muscle training on peak cough flow in patients with Parkinson’s disease: A randomized controlled study. Clinical Rehabilitation, 32(10), 1317–1327. CrossRef
34.
go back to reference Ebersbach, G., et al. (2015). Amplitude-oriented exercise in Parkinson’s disease: A randomized study comparing LSVT-BIG and a short training protocol. Journal of Neural Transmission (Vienna), 122(2), 253–256. CrossRef Ebersbach, G., et al. (2015). Amplitude-oriented exercise in Parkinson’s disease: A randomized study comparing LSVT-BIG and a short training protocol. Journal of Neural Transmission (Vienna), 122(2), 253–256. CrossRef
35.
go back to reference Volpe, D., et al. (2017). Water-based vs. non-water-based physiotherapy for rehabilitation of postural deformities in Parkinson's disease: a randomized controlled pilot study. Clinical Rehabilitation, 31(8), 1107–1115. Volpe, D., et al. (2017). Water-based vs. non-water-based physiotherapy for rehabilitation of postural deformities in Parkinson's disease: a randomized controlled pilot study. Clinical Rehabilitation, 31(8), 1107–1115.
Metagegevens
Titel
Neurologische aandoeningen – ziekte van Parkinson
Auteur
Dr. M. J. Nijkrake
Copyright
2022
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2785-0_7